Combined allogeneic nk cell and herzuma((r)) is effective in her2-low breast cancer preclinical model by enhancing antibody-dependent cellular cytotoxicity
Regular and Young Investigator Award Abstracts（2022）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined